Cadian Capital Management, LP Guardant Health, Inc. Transaction History
Cadian Capital Management, LP
- $2.34 Billion
- Q1 2025
A detailed history of Cadian Capital Management, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 4,595,087 shares of GH stock, worth $170 Million. This represents 8.38% of its overall portfolio holdings.
Number of Shares
4,595,087
Previous 5,221,565
12.0%
Holding current value
$170 Million
Previous $160 Million
22.71%
% of portfolio
8.38%
Previous 9.25%
Shares
6 transactions
Others Institutions Holding GH
# of Institutions
392Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$448 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$417 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$202 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$191 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$188 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.79B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...